查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553691

化療引起的脫髮症(CIA) 治療設備市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、銷售形式、適應症、最終用途、地區和細分市場進行的預測

Chemotherapy-induced Alopecia Treatment Device Market Size, Share & Trends Analysis Report By Product (Manual Cooling Systems, Automated Cooling Systems), By Sales Modality, By Indication, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

化療引起的脫髮症（CIA）治療設備市場成長與趨勢：

根據統計，到2030年，全球化療引起的脫髮(CIA)治療設備市場規模預計將達到1.747億美元，到2030年，全球化療引起的脫髮症(CIA)治療設備市場規模預計將達到1.747億美元。 View Research, Inc. 的最新報告預計複合年成長率為14.6%。

推動市場的主要因素是化療採用率的增加、技術進步、意識和採用率的提高以及政府措施。美國癌症協會預測，到 2024 年，美國將新增約 67,880 例宮癌病例，約 13,250 名女性將死於此病。如此高的病例量凸顯了對有效治療方案的持續需求，包括化療引起的脫髮症(CIA) 治療設備。由於許多患者接受化療，對解決脫髮問題的解決方案的需求不斷增加，這凸顯了 CIA 治療設備在支持女性癌症治療過程中的重要性。

化療引起的脫髮症（CIA）治療設備的進步正在推動市場成長。根據 2024 年 3 月發表的 NCBI 論文，冷帽是一種減少化療引起的脫髮症(CIA)的非藥理學的處置方法，因其在治療期間保留頭髮的潛力而得到認可。在一項研究中，檢驗了手動冷蓋系統在不同患者群體中的實際有效性和耐受性，在 100 名開始冷蓋的患者中，95% 完成了該過程。中位數頭髮保留率為 75%，據報道，92.1% 的患者保留了 50% 或更多的頭髮。

化療引起的脫髮症(CIA) 治療設備市場報告亮點：

  • 由於產品不斷進步、主要企業不斷擴大舉措以及癌症發病率不斷上升，手動冷卻系統細分市場在 2023 年以 52.7% 的最高收益佔有率引領市場。
  • 從銷售業態來看，租賃銷售業以 2023 年銷售佔有率最大的 80.9% 領先市場。患者對頭皮冷卻系統的認知不斷提高，推動了租賃選擇的需求。隨著越來越多的人尋求減輕化療引起的脫髮，醫療保健提供者正在擴大其服務範圍，包括租賃計劃以增加可及性。
  • 有跡象表明，乳癌領域在2023年以66.9%的最大銷售佔有率引領市場。乳癌發病率的上升、技術的進步和意識的提高正在推動市場的成長。
  • 按最終用途分類，醫院細分市場在 2023 年以 44.8% 的最高收益佔有率引領市場。醫院正在將這些 CIA 設備納入其腫瘤科，為患者提供一種行之有效的方法來緩解化療相關的脫髮。
  • 北美地區在 2023 年以 52.8% 的最大收益佔有率主導市場。癌症患者數量的增加、產品的推出、監管部門的核准和先進的醫療基礎設施正在推動北美對 CIA 治療設備的需求。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球化療誘發脫髮症(CIA) 治療設備市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 化療引起的脫髮症（CIA）治療設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章化療引起的脫髮症（CIA）治療設備市場：按產品估計和趨勢分析

  • 化療誘發脫髮症(CIA) 治療設備市場：產品儀表板
  • 化療脫髮症（CIA）治療器材市場：產品波動分析
  • 2018-2030年化療引起的脫髮症（CIA）治療設備市場規模及預測與趨勢分析（按產品）
  • 手動冷卻系統
  • 自動冷卻系統

第5章化療引起的脫髮症（CIA）治療設備市場：按銷售形式估算和趨勢分析

  • 化療誘發脫髮症(CIA) 治療設備市場：銷售方式儀表板
  • 化療脫髮症（CIA）治療器材市場：銷售業態波動分析
  • 2018-2030年化療引起的脫髮症（CIA）治療設備市場規模、預測和趨勢分析（按銷售形式）
  • 出租銷售
  • 直銷

第6章化療引起的脫髮症（CIA）治療設備市場：按適應症的估計和趨勢分析

  • 化療誘發脫髮症(CIA) 治療設備市場：適應症儀表板
  • 化療引起的脫髮症（CIA）治療設備市場：適應症變化分析
  • 2018-2030年化療引起的脫髮症（CIA）治療設備市場規模及預測與趨勢分析（依適應症）
  • 乳癌
  • 攝護腺癌
  • 卵巢癌
  • 子宮癌
  • 其他

第7章化療引起的脫髮症（CIA）治療設備市場：按最終用途分類的估計和趨勢分析

  • 化療誘發脫髮症(CIA) 治療設備市場：最終用途儀表板
  • 化療引起的脫髮症（CIA）治療設備市場：最終用途變化分析
  • 2018-2030 年化療引起的脫髮症(CIA) 治療設備市場規模、預測和趨勢分析（按最終用途）
  • 醫院
  • 癌症中心
  • 門診

第 8 章化療引起的脫髮症(CIA) 治療設備市場：按國家、產品、適應症、銷售形式和最終用途分類的區域估計和趨勢分析

  • 全球化療誘發脫髮症(CIA) 治療設備市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Dignitana
    • Paxman
    • Penguin Cold Caps
    • Chemotherapy Cold Caps, Inc.
    • Aspen Systems, LLC's
    • Cooler Heads Care, Inc.
    • Arctic Cold Caps, LLC
    • Stemtech Medical Devices
    • Polar Cold Caps LLC
Product Code: GVR-4-68040-433-6

Chemotherapy-induced Alopecia Treatment Device Market Growth & Trends:

The global chemotherapy induced alopecia treatment device market size is anticipated to reach USD 174.7 million by 2030 and is projected to grow at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are increasing chemotherapy adoption, technological advancements, growing awareness & adoption, and government initiatives. In 2024, the American Cancer Society forecasts around 67,880 new cases of uterine cancer in the United States, with approximately 13,250 women expected to die from the disease. This significant number of cases highlights an ongoing need for effective treatment options, including chemotherapy-induced alopecia (CIA) treatment devices. As many of these patients undergo chemotherapy, there will be an increased demand for solutions that address hair loss, underscoring the importance of CIA treatment devices in supporting women through their cancer treatment journey

Advancements in chemotherapy-induced alopecia (CIA) treatment devices are driving the market growth. According to NCBI article published in March 2024, Cold capping, a non-pharmacologic approach to reducing chemotherapy-induced alopecia (CIA), is gaining recognition for its potential to preserve hair during treatment. A study reviewing the real-world effectiveness and tolerability of a manual cold capping system across diverse patient demographics found that 95% of the 100 patients who initiated cold capping completed the process. The median hair retention was reported at 75%, with 92.1% of patients achieving favorable results, defined as retaining 50% or more of their hair.

Chemotherapy-induced Alopecia Treatment Device Market Report Highlights:

  • The manual cooling systems segment led the market with the largest revenue share of 52.7% in 2023, due to ongoing product advancements, growing initiatives by key companies, and increasing cancer prevalence
  • Based on sales modality, the rental sales segment led the market with the largest revenue share of 80.9% in 2023. Growing patient awareness of scalp cooling systems has increased demand for rental options. As more individuals seek to mitigate chemotherapy-induced hair loss, healthcare providers are expanding their services to include rental programs, enhancing accessibility
  • Based on indication, the breast cancer segment led the market with the largest revenue share of 66.9% in 2023. Rising incidence of breast cancer, technological advancement, and growing awareness drive the market growth
  • Based on end use, the hospital segment led the market with the largest revenue share at 44.8% in 2023. Hospitals are integrating these CIA devices into their oncology departments to offer patients a proven method for mitigating chemotherapy-related hair loss
  • North America dominated the market with the largest revenue share of 52.8% in 2023. Rising cancer cases, product launches, regulatory approvals, and advanced healthcare infrastructure drive North America's demand for CIA treatment devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Sales Modality
    • 1.2.3. Indication
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Sales Modality Segment
    • 2.2.3. Indication Segment
    • 2.2.4. End Use Segment
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Chemotherapy Induced Alopecia (CIA) Treatment Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Increasing prevalence of chemotherapy-induced alopecia
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Growing Awareness and Adoption
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low product awareness
      • 3.2.2.2. Limited number of manufacturers
  • 3.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Estimates & Trend Analysis

  • 4.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Dashboard
  • 4.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Product Movement Analysis
  • 4.3. Chemotherapy Induced Alopecia (CIA) Treatment Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Manual Cooling Systems
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Automated Cooling Systems
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Estimates & Trend Analysis

  • 5.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Dashboard
  • 5.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Sales Modality Movement Analysis
  • 5.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Sales Modality, 2018 to 2030 (USD Million)
  • 5.4. Rental Sales
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Direct Sales
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Estimates & Trend Analysis

  • 6.1. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Dashboard
  • 6.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Indication Movement Analysis
  • 6.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Breast Cancer
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Prostate Cancer
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Ovarian Cancer
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.7. Uterine Cancer
    • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Estimates & Trend Analysis

  • 7.1. Chemotherapy Induced Alopecia (CIA) Treatment Device market: End Use Dashboard
  • 7.2. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: End Use Movement Analysis
  • 7.3. Chemotherapy Induced Alopecia (CIA) Treatment Device Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Cancer Centers
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Outpatient Clinics
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Chemotherapy Induced Alopecia (CIA) Treatment Device Market: Regional Estimates & Trend Analysis by Country, Product, Indication, Sales Modality, & End Use

  • 8.1. Global Chemotherapy induced alopecia (CIA) treatment device market: Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Regulatory framework/ reimbursement structure
      • 8.3.4.3. Competitive scenario
      • 8.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.4.9. Denmark
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. Dignitana
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Paxman
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Penguin Cold Caps
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Chemotherapy Cold Caps, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Aspen Systems, LLC's
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Cooler Heads Care, Inc.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Arctic Cold Caps, LLC
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Stemtech Medical Devices
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Polar Cold Caps LLC
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 5 Global Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Global Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030
  • Table 7 Global Chemotherapy induced alopecia (CIA) treatment device market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 11 North America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 12 North America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 15 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 19 Canada Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 20 Canada Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 23 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Mexico Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 28 Europe Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Europe Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 32 UK Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 33 UK Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 36 Germany Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Germany Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 39 France Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 40 France Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 41 France Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 44 Italy Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 45 Italy Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 48 Spain Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 52 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Denmark Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 56 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Sweden Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 59 Norway Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 60 Norway Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 61 Norway Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 68 Japan Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 69 Japan Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Japan Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 72 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 73 China Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 74 China Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 76 India Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 77 India Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 78 India Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 80 Australia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 81 Australia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 82 Australia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 83 Australia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 86 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 87 Thailand Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 89 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 90 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 91 South Korea Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 95 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 96 Latin America Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 99 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 100 Brazil Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 103 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 104 Argentina Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 105 MEA Chemotherapy induced alopecia (CIA) treatment device market, by country, 2018 - 2030 (USD Million)
  • Table 106 MEA Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 107 MEA Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 108 MEA Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 109 MEA Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 110 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 112 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 113 South Africa Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 UAE Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 119 UAE Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 120 UAE Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 121 UAE Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by sales modality, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by indication, 2018 - 2030 (USD Million)
  • Table 125 Kuwait Chemotherapy induced alopecia (CIA) treatment device market, by End Use, 2018 - 2030 (USD Million)
  • Table 126 Participant's overview
  • Table 127 Financial performance
  • Table 128 Key companies undergoing expansions
  • Table 129 Key companies undergoing acquisitions
  • Table 130 Key companies undergoing collaborations
  • Table 131 Key companies launching new products
  • Table 132 Key companies undergoing partnerships
  • Table 133 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Chemotherapy induced alopecia (CIA) treatment device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Chemotherapy induced alopecia (CIA) treatment device market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Chemotherapy induced alopecia (CIA) treatment device market Product outlook:
  • Fig. 14 Chemotherapy induced alopecia (CIA) treatment device market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global manual cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 17 Global automated cooling systems market, 2018 - 2030 (USD Million)
  • Fig. 18 Chemotherapy induced alopecia (CIA) treatment device market Sales modality outlook:
  • Fig. 19 Chemotherapy induced alopecia (CIA) treatment device market: Sales modality movement analysis
  • Fig. 20 Global rental sales market, 2018 - 2030 (USD Million)
  • Fig. 21 Global direct sales market, 2018 - 2030 (USD Million)
  • Fig. 22 Chemotherapy induced alopecia (CIA) treatment device market Indication outlook:
  • Fig. 23 Chemotherapy induced alopecia (CIA) treatment device market: Indication movement analysis
  • Fig. 24 Global breast cancer market, 2018 - 2030 (USD Million)
  • Fig. 25 Global prostate cancer market, 2018 - 2030 (USD Million)
  • Fig. 26 Global ovarian cancer market, 2018 - 2030 (USD Million)
  • Fig. 27 Global uterine cancer market, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market, 2018 - 2030 (USD Million)
  • Fig. 29 Chemotherapy induced alopecia (CIA) treatment device market End Use outlook:
  • Fig. 30 Chemotherapy induced alopecia (CIA) treatment device market: End Use movement analysis
  • Fig. 31 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 32 Global cancer centers market, 2018 - 2030 (USD Million)
  • Fig. 33 Global outpatient clinics market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional market place: Key takeaways
  • Fig. 35 North America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 42 France Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 47 China Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 48 India Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia Chemotherapy induced alopecia (CIA) treatment device market, 2018 - 2030 (USD Million)
  • Fig. 55 Market Participant Categorization
  • Fig. 56 Strategy mapping